Skip to Main Content

Paper Details

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.
J Oncol
5
2015
IMP3, Metastatic renal cell carcinoma, Patients, Sarcomatoid Metastatic Renal Cell Carcinoma, SmRCC, VEGF, mTOR, mammalian target of rapamycin, patients, rapamycin, tumor, vascular endothelial growth factor
Author NameAffiliation
Srinivas K TantravahiUniversity of Utah Huntsman Cancer Institute
Neeraj AgarwalUniversity of Utah Huntsman Cancer Institute
  • 1 - 2

Datasets

Release 1.2